Filter Results:
(2,468)
Show Results For
- All HBS Web
(3,262)
- People (5)
- News (372)
- Research (2,468)
- Events (10)
- Multimedia (9)
- Faculty Publications (2,084)
Show Results For
- All HBS Web
(3,262)
- People (5)
- News (372)
- Research (2,468)
- Events (10)
- Multimedia (9)
- Faculty Publications (2,084)
Sort by
- March 1973 (Revised August 1984)
- Background Note
Conglomerates and the Merger Movement of the 1960s
Chandler, Alfred D., Jr. "Conglomerates and the Merger Movement of the 1960s." Harvard Business School Background Note 373-250, March 1973. (Revised August 1984.)
- August 2018 (Revised July 2020)
- Supplement
The Fuji-Xerox Merger (B)
By: Guhan Subramanian and Annie Zhao
Subramanian, Guhan, and Annie Zhao. "The Fuji-Xerox Merger (B)." Harvard Business School Supplement 919-005, August 2018. (Revised July 2020.)
- March 2015 (Revised June 2018)
- Case
Microsoft's aQuantive Acquisition
By: Gwen Yu, Christopher Noe, Joseph Weber and Thomas Samuelson
Yu, Gwen, Christopher Noe, Joseph Weber, and Thomas Samuelson. "Microsoft's aQuantive Acquisition." Harvard Business School Case 115-039, March 2015. (Revised June 2018.)
- February 2010 (Revised September 2011)
- Case
Roche's Acquisition of Genentech
By: Carliss Y. Baldwin, Bo Becker and Vincent Marie Dessain
Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, the pros and... View Details
Keywords: Mergers and Acquisitions; Business Subsidiaries; Negotiation Offer; Organizational Culture; Corporate Strategy; Biotechnology Industry; Pharmaceutical Industry; Switzerland
Baldwin, Carliss Y., Bo Becker, and Vincent Marie Dessain. "Roche's Acquisition of Genentech." Harvard Business School Case 210-040, February 2010. (Revised September 2011.)
- Research Summary
Do Vertical Mergers facilitate Collusion?
Joint work with Volker Nocke, University of Pennsylvania In this paper we investigate the impact of vertical mergers on upstream firms' ability to sustain collusion. We show in a number of models that the net effect of vertical integration is to facilitate... View Details
- October 2019
- Case
Impax Laboratories: Executing Accretive Acquisitions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (A)." Harvard Business School Case 220-030, October 2019.
- November 2005 (Revised February 2009)
- Case
Publicis Groupe: Leading Creative Acquisitions
By: Rosabeth M. Kanter and Ryan Raffaelli
The CEO of a French-based advertising agency network led a series of high-profile acquisitions that created the world's 4th largest global communications company, after a failed strategic alliance taught him lessons about leadership and business relationships. View Details
Keywords: Mergers and Acquisitions; Leadership; Management Succession; Partners and Partnerships; Cooperation; Integration; France
Kanter, Rosabeth M., and Ryan Raffaelli. "Publicis Groupe: Leading Creative Acquisitions." Harvard Business School Case 506-010, November 2005. (Revised February 2009.)
- October 1997 (Revised December 1997)
- Case
Arrow Electronics: The Schweber Acquisition
The CEO of Arrow is about to negotiate the acquisition of a smaller competitor to achieve economies of scale. The case presents data to permit evaluation of prices to bid and negotiating strategy. View Details
Rosenbloom, Richard S., and Stephen Kaufman. "Arrow Electronics: The Schweber Acquisition." Harvard Business School Case 798-020, October 1997. (Revised December 1997.)
- May 28, 2015
- Article
The Good Merger
By: Leemore S. Dafny and Thomas H. Lee
Dafny, Leemore S., and Thomas H. Lee. "The Good Merger." New England Journal of Medicine 372, no. 22 (May 28, 2015): 2077–2079.
- February 2014 (Revised June 2016)
- Case
Mylan Laboratories' Proposed Merger with King Pharmaceutical
By: Lucy White and Matt Kozlowski
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
Keywords: Mergers and Acquisitions; Voting; Ethics; Stock Shares; Investment; Lawsuits and Litigation; Ownership Stake
White, Lucy, and Matt Kozlowski. "Mylan Laboratories' Proposed Merger with King Pharmaceutical." Harvard Business School Case 214-078, February 2014. (Revised June 2016.)
- 29 Nov 2022
- Cold Call Podcast
How Will Gamers and Investors Respond to Microsoft’s Acquisition of Activision Blizzard?
- May 2014 (Revised June 2016)
- Supplement
Mylan Lab's Proposed Merger with King Pharmaceuticals—courseware
By: Lucy White
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
- October 2019
- Supplement
Impax Laboratories: Executing Accretive Acquisitions (B)
By: Benjamin C. Esty and Daniel Fisher
Explores events after Impax announced the acquisition of a portfolio of generic pharmaceutical products from Teva in June 2016. View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Financial Strategy; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (B)." Harvard Business School Supplement 220-031, October 2019.
- December 2014
- Article
The Real Product Market Impact of Mergers
By: Albert Sheen
I document sources of value creation in mergers by analyzing novel data on the quality and price of goods sold by merging firms. When two competitors in a product market merge, their products converge in quality, and prices fall relative to the competition. These... View Details
Sheen, Albert. "The Real Product Market Impact of Mergers." Journal of Finance 69, no. 6 (December 2014).
- 22 Jul 2005
- Keynote Speech
Mergers and Acquisitions: Constructive or Destructive Force of Change?
By: W. Carl Kester
- October 2008 (Revised May 2009)
- Supplement
Kmart and ESL Investments (B): The Sears Merger
By: Stuart C. Gilson and Sarah Abbott
Supplement to 209-044 View Details
Gilson, Stuart C., and Sarah Abbott. "Kmart and ESL Investments (B): The Sears Merger." Harvard Business School Supplement 209-045, October 2008. (Revised May 2009.)
- winter 1998
- Article
Negotiating Cross-Border Acquisitions
Sebenius, James K. "Negotiating Cross-Border Acquisitions." MIT Sloan Management Review 39, no. 2 (winter 1998): 27–41. (Reprinted in Cross-Cultural Management, Gordon Redding and Bruce W. Stening, eds., Surrey: Edward Elgar Publishing, 2002.)
- April 1998 (Revised July 2005)
- Case
Acquisition of Consolidated Rail Corporation (A), The
By: Benjamin C. Esty, Lori A. Flees and Mathew M Millett
On October 15, 1996, Virginia-based CSX and Pennsylvania-based Consolidated Rail (Conrail), the first and third largest railroads in the eastern United States, announced their intent to merge in a friendly deal worth $8.3 billion. This deal was part of an industry-wide... View Details
Esty, Benjamin C., Lori A. Flees, and Mathew M Millett. "Acquisition of Consolidated Rail Corporation (A), The." Harvard Business School Case 298-006, April 1998. (Revised July 2005.)
- December 2018 (Revised February 2019)
- Teaching Note
Merger Arbitrage at Tannenberg Capital
By: Samuel G. Hanson
Teaching Note for HBS Nos. 218-065 and 218-066. View Details
- July 2005
- Teaching Note
Utah Symphony and Utah Opera: A Merger Proposal (TN)
By: Thomas J. DeLong
Teaching Note to (9-404-116). View Details